At close: December 20 at 8:13:48 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
-6,651.0000
--
6,651.0000
--
Operating Expense
41,604.0000
--
45,876.0000
36,693.0000
Operating Income
-48,255.0000
--
-39,225.0000
-36,693.0000
Other Income Expense
-5,170.0000
--
-3,522.0000
-324.0000
Pretax Income
-53,425.0000
--
-42,747.0000
-37,017.0000
Tax Provision
318.0000
--
62.0000
547.0000
Net Income Common Stockholders
-53,743.0000
--
-42,809.0000
-37,564.0000
Diluted NI Available to Com Stockholders
-53,743.0000
--
-42,809.0000
-37,564.0000
Basic EPS
-4.51
-4.51
-3.59
-3.15
Diluted EPS
-4.51
-4.51
-3.59
-3.15
Basic Average Shares
11,929.5280
11,929.5280
11,929.5280
11,929.5280
Diluted Average Shares
11,929.5280
11,929.5280
11,929.5280
11,929.5280
Total Operating Income as Reported
-48,255.0000
--
-39,225.0000
-36,693.0000
Total Expenses
41,604.0000
--
45,876.0000
36,693.0000
Net Income from Continuing & Discontinued Operation
-53,743.0000
--
-42,809.0000
-37,564.0000
Normalized Income
-48,850.5300
--
-40,407.0000
-37,564.0000
EBIT
-48,255.0000
--
-39,225.0000
-36,693.0000
EBITDA
-47,756.0000
--
-38,855.0000
-36,646.0000
Reconciled Depreciation
499.0000
--
370.0000
47.0000
Net Income from Continuing Operation Net Minority Interest
-53,743.0000
--
-42,809.0000
-37,564.0000
Total Unusual Items Excluding Goodwill
-6,193.0000
--
-2,402.0000
--
Total Unusual Items
-6,193.0000
--
-2,402.0000
--
Normalized EBITDA
-41,563.0000
--
-36,453.0000
-36,646.0000
Tax Rate for Calcs
0.0002
--
--
--
Tax Effect of Unusual Items
-1,300.5300
--
--
--
12/31/2021 - 4/4/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
9U90.MU Unity Biotechnology Inc
0.9800
-2.97%
PRNAF Alterity Therapeutics Limited
0.0036
0.00%
6JH.MU IN8bio, Inc.
0.2360
-10.61%
6JH.F IN8bio, Inc.
0.2280
-10.94%
LVCLF Algorae Pharmaceuticals Limited
0.0051
0.00%
PX91.MU Cassava Sciences Inc
2.2475
+1.95%
OCEAW Ocean Biomedical, Inc.
0.0354
-9.23%
HMTXF Hemostemix Inc.
0.0468
0.00%
CEROW CERo Therapeutics Holdings, Inc.
0.0090
-14.29%
PYPD PolyPid Ltd.
3.2200
-6.94%